View Post

Extended estrogen suppression treatment found safe for postmenopausal breast cancer patients

In In The News by Barbara Jacoby

Source:Elsevier From: news-medical.net New evidence shows that extended estrogen suppression treatment using an aromatase inhibitors for hormone receptor-positive postmenopausal breast cancer is safe; it does not increase the risk of coronary artery calcification, a sign of active coronary atherosclerosis, as some prior studies had indicated. An article in the Canadian Journal of Cardiology, published by Elsevier, details the findings from …

View Post

European Study Provides More Evidence Supporting IceCure’s ProSense® is Safe & Effective Cryoablation Treatment for Metastatic and Recurrent Breast Cancer

In In The News by Barbara Jacoby

Source: IceCure Medical From: prnewswire.com Independent, third-party data published in highly influential peer-reviewed journal, Cancers, concluded cryoablation with ProSense® is a safe, local treatment for breast cancer with low complication rate, high complete ablation rate and satisfactory overall survival (OS), progression free survival (PFS) and local tumor control 8.9% recurrence rate in population of 45 patients who had previously received various …

View Post

Premastectomy Radiotherapy Followed by Immediate Breast Reconstruction Demonstrates Safety

In In The News by Barbara Jacoby

By: Lori Solomon From: healthday.com Premastectomy radiotherapy (PreMRT) and regional node irradiation (RNI) followed by immediate breast reconstruction (IMBR) is feasible and safe, according to a study published online April 5 in JAMA Network Open. Mark V. Schaverien, M.D., from University of Texas MD Anderson Cancer Center in Houston, and colleagues assessed the feasibility and safety of PreMRT followed by mastectomy …

View Post

Breast cancer vaccine safely generates anti-tumor immunity

In In The News by Barbara Jacoby

By: Michael McCarthy. From: newsroom.uw.edu Study findings suggest that a vaccine could be used to prevent or treat a particularly aggressive form of breast cancer. An experimental vaccine against breast cancer safely generated a strong immune response to a key tumor protein, researchers from the University of Washington School of Medicine in Seattle report in a paper published by the journal …

View Post

Breast-Conserving Surgery Safe for Deeply Seated Breast Cancer

In In The News by Barbara Jacoby

By: Deborah L. Ungerleider, MD From: medscape.com The study covered in this summary was published on ResearchSquare.com as a preprint and has not yet been peer reviewed. Key Takeaways When performing breast-conserving surgery, the retroglandular approach via incision in the inframammary fold for excision of a retroglandular tumor is feasible and safe. This incision gives better cosmetic results while allowing …

View Post

What to know about breast cancer and soy

In In The News by Barbara Jacoby

From: medicalnewstoday.com Soy is a type of legume that contains plant compounds called phytoestrogens. These compounds share similarities with the hormone estrogen, which plays a role in the development of certain breast cancers. For this reason, scientists have investigated whether soy may affect breast cancer development and progression. Breast cancer is the most commonTrusted Source cancer globally. Though treatment advances …

View Post

Large Analysis Confirms Safety of Nipple-Sparing Mastectomy

In In The News by Barbara Jacoby

By: Donavyn Coffey From: medscape.com A new analysis of over 22,000 mastectomy patients confirms what smaller studies have indicated: Patients who undergo nipple-sparing mastectomy have similar overall and disease-free survival to those who receive a total mastectomy. When nipple-sparing mastectomy was introduced, many experts felt uneasy about opting for the less invasive procedure, recalled Rosa Hwang, MD, associate medical director …

View Post

Junjie Li, MD, on Capecitabine in Triple-Negative Breast Cancer

In Clinical Studies News by Barbara Jacoby

By: Jeff Minerd From: medpagetoday.com Clinical trial focused exclusively on TNBC patients Current breast cancer treatment guidelines suggest that capecitabine (Xeloda) should be considered for adjuvant treatment after standard neoadjuvant therapy with taxane- and anthracycline-based chemotherapy. However, although randomized trials have evaluated capecitabine as adjuvant treatment in breast cancer overall as well as in elderly patients, none have focused solely …

View Post

Can Complementary Therapies Help Breast Cancer Patients?

In In The News by Barbara Jacoby

By: Plastic Surgeon and Breast Reconstruction Specialist Dr. Constance Chen From: prweb.com Breast cancer, the most commonly occurring cancer in women, is traditionally treated with a combination of surgery, radiation, and chemotherapy. In seeking to maximize the benefits of these treatments and minimize their often-debilitating side effects, many women consider adding various complementary therapies to their treatment regimens. “Complementary therapies …

View Post

Alteogen confirms safety, efficacy of HER2 breast cancer therapy

In Clinical Studies News by Barbara Jacoby

By: Shim Hyun-tai From: koreabiomed.com The American Society of Clinical Oncology (ASCO) is one of the most noteworthy events in the global biotech industry as it provides an opportunity to gauge the clinical success of pipelines for pharmaceuticals on the global stage. This is the sixth in a series of articles Korea Biomedical Review publishes to present the key clinical …